Copyright
©The Author(s) 2023.
World J Gastroenterol. Jan 14, 2023; 29(2): 310-331
Published online Jan 14, 2023. doi: 10.3748/wjg.v29.i2.310
Published online Jan 14, 2023. doi: 10.3748/wjg.v29.i2.310
Figure 1 A schematic description of the Janus kinase/STAT pathway.
1: Cytokine and cytokine receptor before interaction; 2: Ligand-reception interaction brings about conformational change that recruits the second cytokine receptor to dimerize with the first cytokine receptor; 3: The activated dimeric receptor recruits Janus kinase (JAK); 4: Thereby causing JAK to phosphorylate itself and the cytoplasmic tail of the cytokine receptor on the tyrosine residue; 5: Activated JAK phosphorylates monomeric STAT transcription factor, hence causing it to disengage from its endogenous inhibitor and dimerize; 6: The activated dimeric signal transducer and activator of transcription translocates to the nucleus; 7: Where it binds to a promoter; 8: That causes the gene expression of some inflammatory markers. JAK: Janus kinase; STAT: Signal transducer and activator of transcription.
- Citation: Johnson TO, Akinsanmi AO, Ejembi SA, Adeyemi OE, Oche JR, Johnson GI, Adegboyega AE. Modern drug discovery for inflammatory bowel disease: The role of computational methods. World J Gastroenterol 2023; 29(2): 310-331
- URL: https://www.wjgnet.com/1007-9327/full/v29/i2/310.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i2.310